ARCHIVES

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

This article is from The Cancer Letter archive.

Vol. 24 No. 15 | April 17, 1998

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

ASCO, NCCS Call For Oncology Center

September 13, 2002

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008